Research map: Targeting tumor transition windows

Back to the article

Papers in this map

  1. Cancer immunotherapy using checkpoint blockade · Antoni Ribas · 2018 · 6969 citations · Cited by this paper
  2. Programmable immune biointerfaces for cell-state control through mechanotransduction, stimuli-responsive design, and AI-guided modeling in regeneration and cancer · Moawiah M. Naffaa · 2026 · Cites this paper
  3. Emerging roles of haemostatic proteins as markers of disease progression and prognosis in breast cancer · 2026 · Related
  4. The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth · Karin E. de Visser · 2023 · 4018 citations · Cited by this paper
  5. FDA 2025 Cancer Drug Approvals: targeted therapy dominates · 2026 · Related
  6. Bacterial Persistence as a Phenotypic Switch · Nathalie Q. Balaban · 2004 · 3116 citations · Cited by this paper
  7. Racial disparities in hepatocellular carcinoma: a TCGA-based gene expression study of Caucasian and Asian populations · 2025 · Related
  8. Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity · Stefani Spranger · 2015 · 2902 citations · Cited by this paper
  9. Metabolic plasticity drives specific mechanisms of chemotherapy and targeted therapy resistance in metastatic colorectal cancer · 2025 · Related
  10. A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations · Sreenath V. Sharma · 2010 · 2863 citations · Cited by this paper
  11. Benign, persistent, and invasive: mechanistic and translational approaches to middle‑ear cholesteatoma · 2026 · Related
  12. Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition · Matthew J. Hangauer · 2017 · 1840 citations · Cited by this paper
  13. Phosphoproteomics of osimertinib-tolerant persister cells reveals targetable kinase-substrate signatures · 2025 · Related
  14. Acquired Resistance to KRAS G12C Inhibition in Cancer · Mark M. Awad · 2021 · 1244 citations · Cited by this paper
  15. Single-cell RNA-sequencing of circulating tumour cells: A practical guide to workflow and translational applications · 2025 · Related
  16. Neoantigen-directed immune escape in lung cancer evolution · Rachel Rosenthal · 2019 · 1012 citations · Cited by this paper
  17. Neoantigen-based immunotherapy: advancing precision medicine in cancer and glioblastoma treatment through discovery and innovation · 2025 · Related
  18. Integrating evolutionary dynamics into treatment of metastatic castrate-resistant prostate cancer · Jingsong Zhang · 2017 · 612 citations · Cited by this paper
  19. KRAS-targeted therapies in cancer: novel approaches and overcoming resistance · 2025 · Related
  20. Cycling cancer persister cells arise from lineages with distinct programs · Yaara Oren · 2021 · 548 citations · Cited by this paper
  21. Transition between cell states of sensitivity reveals molecular vulnerability of drug-tolerant cells · 2025 · Related
  22. Colorectal Cancer Cells Enter a Diapause-like DTP State to Survive Chemotherapy · Sumaiyah K. Rehman · 2021 · 521 citations · Cited by this paper
  23. Vertical Pathway Inhibition Overcomes Adaptive Feedback Resistance to KRASG12C Inhibition · Meagan B. Ryan · 2019 · 513 citations · Cited by this paper
  24. Mechanisms regulating PD-L1 expression on tumor and immune cells · Shuming Chen · 2019 · 475 citations · Cited by this paper
  25. Targeting cytokine and chemokine signaling pathways for cancer therapy · Ming Yi · 2024 · 452 citations · Cited by this paper
  26. Quantifying the Expanding Landscape of Clinical Actionability for Patients with Cancer · Sarah Phillips Suehnholz · 2023 · 432 citations · Cited by this paper
  27. Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA · Christopher Abbosh · 2023 · 388 citations · Cited by this paper
  28. Hypoxia, oxidative stress, and the interplay of HIFs and NRF2 signaling in cancer · Taegeun Bae · 2024 · 336 citations · Cited by this paper
  29. Hallmarks of cancer stemness · Jia-Jian Loh · 2024 · 309 citations · Cited by this paper
  30. Single-cell transcriptional changes associated with drug tolerance and response to combination therapies in cancer · Alexandre F. Aissa · 2021 · 289 citations · Cited by this paper
  31. Candidate mechanisms of acquired resistance to first-line osimertinib in EGFR-mutated advanced non-small cell lung cancer · Juliann Chmielecki · 2023 · 271 citations · Cited by this paper
  32. KRAS Secondary Mutations That Confer Acquired Resistance to KRAS G12C Inhibitors, Sotorasib and Adagrasib, and Overcoming Strategies: Insights From In Vitro Experiments · T. Koga · 2021 · 264 citations · Cited by this paper
  33. Tumor cell plasticity in targeted therapy-induced resistance: mechanisms and new strategies · Zhenduo Shi · 2023 · 255 citations · Cited by this paper
  34. Therapeutic advances of targeting receptor tyrosine kinases in cancer · Ciprian Tomuleasa · 2024 · 255 citations · Cited by this paper
  35. Sublethal cytochrome c release generates drug-tolerant persister cells · Halime Kalkavan · 2022 · 254 citations · Cited by this paper
  36. Circulating tumor DNA to monitor treatment response in solid tumors and advance precision oncology · Alexandra Bartolomucci · 2025 · 238 citations · Cited by this paper
  37. Cancer associated fibroblasts in cancer development and therapy · Hongyuan Jia · 2025 · 217 citations · Cited by this paper
  38. Epigenetic regulation during cancer transitions across 11 tumour types · Nadezhda V. Terekhanova · 2023 · 215 citations · Cited by this paper
  39. Mitochondrial metabolism and cancer therapeutic innovation · Hongxiang Du · 2025 · 205 citations · Cited by this paper

Source: OpenAlex (CC0)